Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
2.8600
+0.0200
+(0.70%)
At close: February 24 at 3:29:02 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-132,943
-116,361
-94,631
-75,443
-37,271
Investing Cash Flow
133,129
-127,012
-150,204
73,699
-210,866
Financing Cash Flow
23,234
274,405
226,854
2,527
213,212
End Cash Position
81,099
64,716
33,684
51,665
50,882
Interest Paid Supplemental Data
2,135
1,149
615
--
--
Capital Expenditure
-3,700
-921
-1,760
-1,953
-1,532
Issuance of Capital Stock
3,338
275,252
217,561
2,984
213,212
Issuance of Debt
19,909
--
10,000
--
--
Free Cash Flow
-136,643
-117,282
-96,391
-77,396
-38,803
12/31/2020 - 6/8/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GXEA.F Galapagos NV
25.60
+1.59%
50BA.SG Bicycle Therapeutics PLC
10.60
-3.64%
AURA Aura Biosciences, Inc.
7.37
-1.86%
BCYC Bicycle Therapeutics plc
11.25
-3.52%
TECX Tectonic Therapeutic, Inc.
27.27
-7.68%
TRVI Trevi Therapeutics, Inc.
4.3100
-6.30%
NCNA NuCana plc
1.0200
-6.42%
CNTA Centessa Pharmaceuticals plc
15.66
-5.83%
URGN UroGen Pharma Ltd.
9.74
-3.37%
PRTA Prothena Corporation plc
15.23
-2.12%